Tracie Napoli - Communication campaign Canada

Tracie Napoli is the Director, Fund Development and Marketing and Communications at Osteoporosis Canada and has been with the organization since 2012. Tracie has worked for local, national and international charities including Children’s Miracle Network, Villa Charities, March of Dimes Canada, Special Olympics Ontario and the MS Society of Canada.

Her fund development, marketing and communication work in the not-for-profit sector exhibits a cross section of experience including volunteer management, event and peer-to-peer fundraising, direct mail, individual giving and corporate partnerships. Tracie steered the initiative to advance Osteoporosis Canada’s trademarks and brand in 2017 with the goal to reach and expand new audiences.

Prior to her career in the not-for-profit sector, Tracie worked in radio and television doing on-air work at local radio stations in Ontario and in TV production for Rogers Television, CTV Sportsnet and the CBC.






Dr. Dawson-Hughes - Strategies to act on low calcium intake worldwide

Dr. Dawson-Hughes, M.D. graduated from Tufts University School of Medicine, completed her house training at Tufts, and completed an endocrine fellowship at Harvard (Brigham and Women's Hospital). She then returned to Tufts where she now directs the Bone Metabolism Laboratory at the USDA Human Nutrition Research Center on Aging. Her academic appointment is Professor of Medicine and she is a member of the Endocrine Division at the Tufts Medical Center. She is the Vice President of the International Osteoporosis Foundation (IOF). In 2012-2016, she was a founding Director of the Center for the Advancement of Science in Space (CASIS). This board directs research and technology development on the International Space Station National Laboratory.

Dr. Dawson-Hughes has served on the Councils of professional organizations, including the American Society for Bone and Mineral Research, the American Society of Clinical Nutrition and the International Bone and Mineral Society. She was the Principal Investigator of the NIH Osteoporosis and Related Bone Diseases Resource Center in Washington, DC from 1998-2003 and served on the Advisory Council of NIAMS from 2000-2004. She was President of the National Osteoporosis Foundation from 2002-2005 and a member of the Board of Trustees from 1995-2012.
Her research is directed at examining ways in which calcium, vitamin D, protein and the acid-base balance of the diet influence bone and muscle loss and risk of fragility fractures in older adults. She has published over 450 peer-reviewed journal articles, book chapters, and reviews. She has received many awards for her research and scientific leadership including the Corson Bolton Medal from the Franklin Institute in Philadelphia, the IOF President’s Metal, and the IOF Award for Scientific Achievement. She was cited in the Thomson Reuters report on ‘Highly Cited Researchers’, which included scientists who had published the greatest number of highly cited papers (in the top 1% of citations) in the field of clinical research in 2002 through 2013.


Dr. Xia - Strategies to act on low calcium intake worldwide

Dr.Xia is interested in bone and mineral disease. He did the study on epidemiological trends of osteoporosis and osteoporotic fracture in China. He conducted many new agents evaluation on osteoporosis in clinical trials. To better understand the pathophysiology of osteoporosis, He carried out some genetic studies in Chinese osteoporotic populations. His research also focused on other metabolic diseases, such as the rickets and osteomalacia, especially on hypophosphatemic rickets, tumor induced osteomalacia, vitamin D deficient rickets and vitamin D dependent rickets. Hypoparathyroidism and hyperparathyroidism are also involved in his research fields. As an editor-in-chief, he conducted “The Chinese Guideline of Primary Hyperparathyroidism” in 2014 and “Chinese Guideline of Clinic Management of Osteoporosis” in 2017, “The Consensus of  Clinical Application of Vitamin D and Its Analogous” ,“Chinese Guideline of Hypoparathyroidism”. As President of Chinese Society of Osteoporosis and Bone Mineral Research (CSOBMR), he collaborated with CDC China completed the Chinese Osteoporosis Prevalence Study (COPS) this year. COPS is the first nation-wide epidemiologic study on osteoporosis in China. As author or Co-author, he has published over 200 scientific papers, including more than 110 SCI papers.


Dr. Ding-Cheng (Derrick) Chan - Strategies to act on low calcium intake worldwide

Dr. Ding-Cheng (Derrick) Chan is the superintendent of National Taiwan University (NTU) Hospital Chu-Tung Branch in Hsinchu, Taiwan. He is also an attending physician of the Department of Geriatrics and Gerontology and clinical associate professor of Internal Medicine at the NTU Hospital in Taipei, Taiwan.

His research focuses on drug-related problems, frailty, sarcopenia, and osteoporosis. In 2014, he plays a central role in developing the “Fracture Liaison Services (FLS)” at the National Taiwan University Hospital and its BeiHu branch. The two programs were accredited as gold medal (NTUH), and silver medal (NTUH-BB) for best practice programs of the 'Capture the Fracture' campaign from International Osteoporosis Foundation (IOF). He worked with the Taiwanese Osteoporosis Association to host workshops to promote FLS network in Taiwan. In March 2017, with 22 programs, TOA received the best secondary fracture prevention campaign award at the WCO-IOF-ESCEO Florence 2017. He played pivotal role in developing the “Consensus on Best Practice Standard for Fracture Liaison Service in the Asia Pacific Region”, and he was a Chair of the Asia Pacific Fragility Fracture Alliance. 

He also actively engaged in academic societies including being the member of Medical Counseling Committee, Ministry of Health and Welfare, secretary general, and board supervisor for the Taiwanese Osteoporosis Association, board member of the Taiwan Association for Comprehensive Care of Chronic Diseases, and Committee Member of the Ministry of Health and Welfare Long-term Care. He was promoted as Fellow of American College of Physician.



Thierry Thomas - Connecting Patient and Policy makers

Thierry Thomas is a Professor of Medicine and Head of the Rheumatology Department at the University Hospital of Saint-Étienne (UHSE), France. He is also a member of the INSERM Unit 1059, the Integrative Biology of Bone Tissue Laboratory. Professor Thomas obtained his medical degree at the University of Saint-Étienne, before specialising in rheumatology and completing a PhD at the University of Lyon, France. After a research fellowship in endocrinology at the Mayo Clinic in Rochester, MN, USA, he joined the faculty at UHSE in 1998, and assumed his current position in 2002. Professor Thomas research interests focus on bone physiology and pathology, as well as shoulder pathologies. He is a member of the International Osteoporosis Foundation (IOF) representing the Groupe de Recherche et d’Information sur les Ostéoporoses (GRIO) at the Committee of National Societies, he is the Past-President of the National College of Academic Teaching in Rheumatology (COFER) and the current President of the French Society of Rheumatology since February 2019. He sits on the editorial boards of Osteoporosis International. He is well published in the medical literature, with more than 220 articles in international peer-reviewed journals.






Alison Doyle - Connecting Patient and Policy makers

Ali is responsible for the delivery of our regional services. Initially trained as a nurse, Ali has over 25 years’ experience working with the NHS, social care and Public Health. She has held roles in operational nursing, strategic development and management, including 10 years focusing on osteoporosis services, fracture prevention, falls and frailty. Ali leads on the development of quality services, and motivating healthcare professionals to ensure the very best care, support and information is available to people with osteoporosis.








Dr. Maria Luisa Brandi - Connecting Patient and Policy makers

Brandi, Maria Luisa Full Professor of Endocrinology, University of Florence, Medical School, Florence, Italy.
Education/Training Positions: MD, University of Florence, Florence, Italy, 1977; School of Specialization in Endocrinology, University of Florence Hospital, 1977-1980; National Institutes of Health (NIH) Visiting Scientist in Metabolic Diseases, Metabolic Diseases Branch, NIH, Bethesda, Maryland, USA, 1984-1990; Ph.D. in Cell Biology, University of Rome, 1988; Assistant, Associate and Full Professor of Endocrinology, University of Florence, 1990-to present; Director, Regional Center on Hereditary Endocrine Tumors, University Hospital of Florence, 1998-to present; Director Clinical Unit on Metabolic Bone Disorders, University Hospital of Florence, 2007-to present; Delegate, Italy/USA Academic Interactions, Florence University, 2000-2003; Director of the University Master on Metabolic Bone Disease: From the Gene to the Cure, University of Florence, 2004-to present; Scientific Director, DeGene Spin-off, University of Florence, 2005-2009; President, Fondazione Italiana Ricerca sulle Malattie dell’Osso (F.I.R.M.O.), 2006 - to present; Consultant for the Tuscany Region on Osteoporosis, 2008 - to present; Member of the Commission for Osteoporosis of the Italian Ministry of Health, 2009 – 2011; Scientific Attaché for the City of Florence 2015 - to present; Delegate of the Rector of the University of Florence for Health Education in the City of Florence, 2016 – to present; Member Steering Committee of the European Reference Centers Network on Rare Bone Diseases, 2016 to present.




Ph.D. Jean-Yves Reginster M.D. - CNS Chair 

Jean-Yves Reginster M.D., Ph.D. is currently Outstanding Professor of Epidemiology, Public Health and Health Economics as well as Professor of Bioethics and Societal Medicine at the University of Liège where he also serves as the Honorary Chair of the Bone and Cartilage Metabolism Unit. He is the Director of the Department of Public Health, Epidemiology and Health Economics at the University of Liège and Director of the WHO Collaborating Centre for Public Health Aspects of Musculoskeletal Health and Aging. He is visiting Professor at the Chair for biomarkers of chronic diseases, Department of Biochemistry, College of Science, King Saud University, Riyadh, Kingdom of Saudi Arabia. He is an active researcher who has authored more than 900 publications, mainly dedicated to the pathophysiology, epidemiology, health economics, clinical and translational aspects of osteoporosis, osteoarthritis, frailty and sarcopenia. Among his other professional activities, Professor Reginster is President of the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO), Co-Founder and Board member of the International Osteoporosis Foundation (IOF), where he serves as President of the Committee of National Societies (CNS). He previously served as Adjunct Professor of Medicine at Georgetown University Medical Center, Washington DC, USA. He was the Belgian alternate member for the Efficacy Working Party at the Committee for Human Proprietary Medicines (CHMP) of the European Medicines Agency (EMA) where he acted as rapporteur/co-rapporteur for the guidelines for the registration of drugs to be used in the management of osteoporosis and osteoarthritis.



Dr. Marla Shapiro - Osteoporosis : The Patient Journey

Dr. Marla Shapiro is a Certificant of the College of Family Physicians of Canada and a Specialist in Community Medicine. She is an Associate Professor in the Department of Family and Community Medicine at the University of Toronto and has her own family practice. The medical consultant for CTV National News and Canada AM, she also hosts the show Balance: Television for Living Well and has a bi-weekly column in The Globe and Mail. Dr. Shapiro is the recipient of the 2005 Media Award from the North American Menopause Society for her work in expanding the understanding of menopause, and won the Society of Obstetricians and Gynaecologists of Canada/Canadian Foundation for Women’s Health Award for Excellence in Women’s Health Journalism in 2006 for her documentary Run Your Own Race. She lives in Toronto with her family.





Elizabeth Thompson - Osteoporosis: The Patient Journey 

Liz Thompson serves as the chief executive officer of the National Osteoporosis Foundation, the nation’s only organization dedicated to preventing osteoporosis and broken bones, promoting strong bones for life and reducing human suffering through awareness programs for the public and clinicians, education, advocacy and research. Osteoporosis is a major public health threat for an estimated 54 million Americans.






Dr. Famida Jiwa - Chair of the Patient Societies Subcommittee of the CNS 

Dr. Jiwa is the President and CEO of Osteoporosis Canada, and has been with the organization since 2006. Prior to joining Osteoporosis Canada, Dr. Jiwa was the former Provincial Osteoporosis Co-ordinator, employed by the Ontario Ministry of Health and Long Term Care and charged with rolling out all aspects of the $5 million annual Ontario Osteoporosis Strategy. Prior to this and after leaving her private practice in Orlando, Florida, Dr. Jiwa was a Program Consultant for the Acute Services Division of the Ministry of Health, where she played a significant role in project planning, implementation and evaluation of a number of provincial health initiatives, including chronic kidney disease, asthma and age-related macular degeneration.
In 2017, Dr. Jiwa was re-elected chair of the Patient Societies Subcommittee of the Committee of National Societies (CNS) of the International Osteoporosis Foundation (IOF) for a 5th term of two years. In 2016, she was awarded the President’s Award from the International Osteoporosis Foundation. She is also the recipient of the Queen Elizabeth II Diamond Jubilee Medal. Dr. Jiwa has also attained the designation of Certified Health Executive from the Canadian College of Health Service Executives, and in 2017 she completed the Strategic Perspectives in Nonprofit Management program at Harvard Business School.
She holds a Masters Degree in Health Administration from the Department of Health Policy, Management and Evaluation from the University of Toronto, a Doctorate of Chiropractic from the Canadian Memorial Chiropractic College in Toronto, as well as an Honours Bachelor of Science, Genetics and Psychology from the University of Toronto.